JPRN-UMIN000007433招募中2 期
A Phase II Study of Carboplatin and S-1 Followed by S-1 Maintenance for Patients Who Have Squamous Cell Lung Carcinoma - CJLSG1102
Central Japan Lung Study Group (CJLSG)0 个研究点目标入组 30 人开始时间: 2012年3月2日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 招募中
- 发起方
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) Active infection or other serious disease condition (poorly controlled diabetes mellitus, cardiac disease, Unstable angina, Cardiac infarction, Psychological illness, etc.). 2) Pulmonary disorder(idiopathic pulmonary fibrosis,interstitial lung disease,pneumoconiosis,active radiation pneumonia,etc.). 3) Massive pleural effusion, pericardial effusion, ascites, and superior vena cava syndrome. 4) Symptomatic brain metastasis. 5) Grade 2 or higher diarrhea 6) Pregnant or nursing females 7) Patients whose participation in the trial is judged to be inappropriate by the attending doctor.
研究者
相似试验
尚未招募
2 期
Phase II Trial of Carboplatin plus S-1 for Previously Untreated Patients with Advanced Non-small-cell Lung Cancer complicated by Interstitial Pneumoniaon-small cell lung cancerJPRN-UMIN000011046Department of Respiratory medicine and Rheumatology, Tokushima University Hospital33
未知
2 期
Phase II study in combination with Carboplatin and TS-1 for Cancer of unknown primaryCancer of unknown primaryJPRN-UMIN000001236ational Cancer Center Hospital, Tokyo35
进行中（未招募）
2 期
A Randomised Phase II Study Of nab-paclitaxel In Combination With Carboplatin As First Line Treatment Of Gastrointestinal Neuroendocrine CarcinomasACTRN12616000958482Australasian Gastro-Intestinal Trials Group (AGITG)60
招募中
1 期
A phase I/II study of carboplatin in combination with nab-paclitaxel and thoracic radiation in elderly patients with previously untreated non-small cell lung cancerocally Advanced Non-Small Cell Lung CancerJPRN-UMIN000016730Foundation for Biomedical Research and Innovation43
招募中
2 期
Phase I/II trial of carboplatin, TS-1, and concurrent radiation therapy in patients with unresectable locally advanced non-small cell lung cancernresectable locally advanced non-small cell lung cancerJPRN-UMIN000011663Dokkyo Medical University40